A pharmaceutical company has developed an online-based tool called the Diabetes Risk Assessment aimed at assessing the Filipino’s risks of getting diabetes.
Novo Nordisk Philippines came up with the easy-to-take survey to help Filipinos prevent the onset of diabetes by addressing risks that are modifiable and avoidable. The survey will also help Filipinos get the proper diagnosis and understand the type of diabetes they have, and ultimately get treatment and management tools that can enable everyone to defeat diabetes together.
Dr. Cecilia Jimeno, an endocrinologist from the University of the Philippines Philippine General Hospital, said the survey, which was created in partnership with the Quezon City Lions Club, was made specifically for Filipinos and to help them become aware of their diabetes risks.
Generally, a chronic illness such as diabetes typically has no cure and can develop complications like heart disease, stroke, blindness, kidney failure, heart failure, loss of a limb, and reduced life expectancy.
A proactive approach to dealing with diabetes is crucial as it will help identify which factors can be controlled and which ones are inevitable.
Dr. Jeremy Jones F. Robles, president of the Philippine Society of Endocrinology, Diabetes and Metabolism Inc, pointed out that Filipinos need to clearly understand that diabetes and obesity are closely related. “The cases of people who are overweight and prediabetic are going up right now,” he said during the press briefing.
“The overall approach is Apat Dapat- proper diet, regular exercise, consistent intake of medicines and regular consultation with the doctor,” he added.
Benefits of knowing your risk
The Diabetes Risk Assessment Online Survey increases awareness, inspires action, and makes diabetes management better for Filipinos. Furthermore, it expects more patients to be more aware of the risks of Type 2 diabetes risk will enable them to act on it with the support of their doctors.
For patients who are diagnosed earlier, they will be able to receive early treatment and optimize their diabetes control to delay complications.
Novo Nordisk Philippines is committed to raise awareness and take action against this disease that affects so many Filipinos. The company’s purpose is to drive change to defeat diabetes by providing access to affordable care and making insulin available at a lower cost.
Continuous efforts are also made by finding new ways to overcome the disease and making donations to several foundations. Novo Nordisk has also partnered up with Quezon City Cubao Lions Club Inc., Philippine Diabetes Support, Philippine Association of Diabetes Educators (PADE), Philippine Center for Diabetes Education Foundation, Inc (PCDEF), Philippine Society of Endocrinology, Diabetes & Metabolism (PSEDM), Institute for Studies on Diabetes Foundation Inc. (ISDF), Diabetes Philippines Inc. (DP), American Association of Clinical Endocrinologists (AACE), and the Danish Embassy to ensure that the information about this campaign is well-distributed to their community of doctors and their patients.